Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms GLR2038 |
Target |
Action degraders |
Mechanism ERs degraders(Estrogen receptors degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced breast cancer | IND Approval | China | 10 Jul 2026 | |
| Estrogen receptor positive breast cancer | IND Application | China | 29 Apr 2026 |





